Mainz Biomed Bv Stock Probability of Future Stock Price Finishing Over 8.98
| MYNZ Stock | USD 0.26 0.03 13.04% |
Mainz |
Mainz Biomed Target Price Odds to finish over 8.98
The tendency of Mainz Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 8.98 or more in 90 days |
| 0.26 | 90 days | 8.98 | close to zero percent |
Based on a normal probability distribution, the odds of Mainz Biomed to move over $ 8.98 or more in 90 days from now is close to zero percent (This Mainz Biomed BV probability density function shows the probability of Mainz Stock to fall within a particular range of prices over 90 days) . Probability of Mainz Biomed BV price to stay between its current price of $ 0.26 and $ 8.98 at the end of the 90-day period is about 57.86 .
Given the investment horizon of 90 days Mainz Biomed BV has a beta of -0.32. This indicates as returns on the benchmark increase, returns on holding Mainz Biomed are expected to decrease at a much lower rate. During a bear market, however, Mainz Biomed BV is likely to outperform the market. Additionally Mainz Biomed BV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Mainz Biomed Price Density |
| Price |
Predictive Modules for Mainz Biomed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mainz Biomed BV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mainz Biomed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mainz Biomed is not an exception. The market had few large corrections towards the Mainz Biomed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mainz Biomed BV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mainz Biomed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | -0.32 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.03 |
Mainz Biomed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mainz Biomed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mainz Biomed BV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mainz Biomed BV generated a negative expected return over the last 90 days | |
| Mainz Biomed BV has high historical volatility and very poor performance | |
| Mainz Biomed BV has some characteristics of a very speculative penny stock | |
| Mainz Biomed BV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 895.48 K. Net Loss for the year was (26.3 M) with profit before overhead, payroll, taxes, and interest of 177.62 K. | |
| Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Mainz Biomed BV has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Mainz Biomed Downgraded by HC Wainwright to Neutral |
Mainz Biomed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mainz Stock often depends not only on the future outlook of the current and potential Mainz Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mainz Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.2 M | |
| Cash And Short Term Investments | 7.1 M |
Mainz Biomed Technical Analysis
Mainz Biomed's future price can be derived by breaking down and analyzing its technical indicators over time. Mainz Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mainz Biomed BV. In general, you should focus on analyzing Mainz Stock price patterns and their correlations with different microeconomic environments and drivers.
Mainz Biomed Predictive Forecast Models
Mainz Biomed's time-series forecasting models is one of many Mainz Biomed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mainz Biomed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Mainz Biomed BV
Checking the ongoing alerts about Mainz Biomed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mainz Biomed BV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mainz Biomed BV generated a negative expected return over the last 90 days | |
| Mainz Biomed BV has high historical volatility and very poor performance | |
| Mainz Biomed BV has some characteristics of a very speculative penny stock | |
| Mainz Biomed BV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 895.48 K. Net Loss for the year was (26.3 M) with profit before overhead, payroll, taxes, and interest of 177.62 K. | |
| Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Mainz Biomed BV has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Mainz Biomed Downgraded by HC Wainwright to Neutral |
Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.